Turquoise Reports
Turquoise Health's Public Comment on CMS-1786-P
Turquoise Health is in full support of CMS’ commitment to continued improvement and iteration of HPT requirements. The proposed requirements would increase efficacy in the overall effort to facilitate healthcare price transparency in the United States.
Download ReportEvaluating the HHS Report on the No Surprises Act
Turquoise Health is tracking all components of The No Surprises Act (NSA), including the First Annual Report. This document focuses on a review of the report, analyzing stalled or broken processes within The NSA, and recommended pathways forward.
Download Report
Price Transparency Impact Report - 2023
Turquoise Health's next Impact Report dives into payer data quality and utility, an update on innovation for upfront, accurate patient estimates, and recommended steps toward improving price transparency data and compliance.
Download Report
Price Transparency Impact Report - 2022
Turquoise Health’s inaugural impact report discussing price transparency regulation, the necessary innovation already happening thanks to third-party organizations, and the various government actions needed for price transparency to fully integrate into the healthcare industry.
Download ReportThird-Party Reports
Testing Savings Assumptions: Shifting Remicade to a Biosimilar
A promising approach to mitigating costs that has gained prominence in recent years among plan sponsors is the utilization of biosimilars, a category of biologic drugs that offer cost-effective alternatives to their branded counterparts. In this report, we dive into Remicade and its biosimilars to determine if they lower cost and how plan sponsors can leverage price transparency data to test this strategy.
Download ReportEvaluating Consistency of Published Rates between Health Plan and Hospital MRF Data
The recent past witnessed transformative innovation in the healthcare industry - the unveiling of price transparency data. This data, sourced from Hospitals and Health Plans, opens a new dimension for cost analysis in healthcare. However, the novelty of this information brought forth several concerns and inquiries about its accuracy, reliability, and consistency. This study explores these concerns, focusing on the alignment of rates in the machine-readable files (MRFs) published by hospitals and health plans.
Download Report